Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT05670574

Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors

Conditions: Small Bowel Cancer, Small Bowel Carcinoid Tumor, Quality of Life, Lymph Node Metastases, Tumor Metastasis

Sex: All

Ages: 18 Years – N/A

Phase: NA

Enrollment: 150

Sponsor: Sykehuset i Vestfold HF

Location: Norway

Summary

The study is designed to investigate the safety and efficacy of central D3 lymphadenectomy in cases of small bowel tumors. Such dissection is under debate; consensus guidelines are vague when it comes to surgical techniques and practice is highly variable.

Eligibility Criteria

Inclusion Criteria:Patients included must be able to fill in an informed, written consent and to understand its implications and contents and to participate in the follow-upRadiologically/scintigraphically/histologically verified extraduodenal tumor(-s) in the small bowel and/or in the mesentery of the small bowelNo signs of inoperabilityFit for general anestheticsExclusion Criteria:Extraduodenal small bowel tumors verified as GIST or benign tumorWidespread lymphoma

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05670574). StuddyBuddy aggregates publicly available trial information.